Eldougdoug, Mohamed W. http://orcid.org/0000-0002-0613-9623
Youssef, Doaa M. http://orcid.org/0000-0001-9948-5690
El-Shal, Amal S. http://orcid.org/0000-0003-2167-8841
Sharaf, Yasmine Ahmed http://orcid.org/0000-0003-0970-7136
Raparla, Sridivya http://orcid.org/0000-0001-5633-8092
Jasti, Bhaskara R. http://orcid.org/0000-0002-6893-1237
Elnahas, Hanan M. http://orcid.org/0000-0002-9148-3276
Funding for this research was provided by:
Zagazig University
Article History
Received: 26 April 2023
Revised: 26 June 2023
Accepted: 2 July 2023
First Online: 24 July 2023
Declarations
:
: The ethics committee represented by the Institutional Review Board (IRB) at the Faculty of Medicine, Zagazig University, gave us approval for collecting blood samples from pediatric patients opportunistically during the duration of treatment (Approval Number; ZU-IRB#6070/26/4/2020). The sample was taken as a comprehensive sample due to the rare attendance of cases (4 cases or less/month), so the committee determined the sample to be 24 cases.
: Parents of pediatric patients in this study signed two consent forms previously determined by the <i>IRB committee.</i> The first one (ZU-IRB #: FORM 2) is for initial acceptance to participate in this study. The second one (ZU-IRB #: FORM 3) is for acceptance to obtain blood samples from the patients for this study.
: The authors declare no competing interests.